Prevention of venous thromboembolism with rivaroxaban and apixaban in orthopedic surgery
Numerous limitations and side effects of standard anticoagulants require administering new anticoagulant drugs. New peroral anticoagulants of Factor Xa inhibitor group have more advantages, the key ones being: substantial reductions in specific nutrition limitations and drug interaction, no need for...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Serbian Medical Society
2020-01-01
|
Series: | Srpski Arhiv za Celokupno Lekarstvo |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2020/0370-81792000063A.pdf |